GlassScriptPhysician profile
Patti G Granzin
NPI 1497792519
$568.62
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $509 · 2022: $42.10 · 2023: $17.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $117.41 | 2021 | |
| Merz Pharmaceuticals, LLC | $100.45 | 2021 | |
| Scilex Pharmaceuticals INC. | $80.15 | 2021 | |
| Abbvie INC. | $56.89 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $55.07 | 2021 | |
| Allergan, INC. | $28.57 | 2021 | |
| Almatica Pharma LLC | $23.05 | 2021 | |
| Pfizer INC. | $17.52 | 2021 | |
| Boston Scientific Corporation | $17.32 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $15.68 | 2021 | |
| Medtronic, INC. | $15.67 | 2021 | |
| Biodelivery Sciences International, INC. | $14.89 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.29 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.66 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patti Granzin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.